EPYSQLI
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for EPYSQLI, covering 2024-07-19 to 2026-08-07. Get the full timeline:
Most recent: EMA Authorised: Epysqli (Eculizumab) — Samsung Bioepis NL B.V.
12 regulatory and trial events tracked for EPYSQLI, covering 2024-07-19 to 2026-08-07. Get the full timeline:
Most recent: EMA Authorised: Epysqli (Eculizumab) — Samsung Bioepis NL B.V.